openPR Logo
Press release

Insulin delivery devices market 2018 – 2024 : Top Players – Sanofi, Ely Lilly, Novo Nordisk, Medtronic, Becton and Dickenson, Roche, Insulet Corporation, Ypsomed

08-22-2018 09:41 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Insulin delivery devices market 2018 – 2024 : Top Players –

Over the past few years, insulin delivery devices market has emerged as one of the most lucrative verticals of the diabetes management industry, given the unprecedented growth in technologies that partially changed the way this chronic disease was managed earlier. The recent announcement by the renowned insulin delivery devices industry giant Tandem Diabetes Care regarding the successful FDA approval of its t:slim X2 Insulin Pump with Basal-IQ technology, is quite an instance validating the product innovation trends underlining the business landscape of this industry.

Incidentally, Basal-IQ is a PLGS (predictive low glucose suspend) feature designed to help lower the duration & frequency of hypoglycemia. Reports in fact claim that Tandem’s device featuring Basal-IQ algorithm looks 30 minutes into the future to foresee where the glucose levels are heading. With such technological innovations & product enhancements in line, it is rather overt that Tandem is set to witness a lucrative growth graph in the years ahead.

Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1649

Eli Lily is another popular name in the insulin delivery devices industry that has been making it to the headlines for developing innovative diabetes management platforms as a part of its Connected Diabetes Ecosystem. The company known for manufacturing insulin is now actively testing its own device that looks similar to a connected insulin pen with in-built software to create personalized insulin dose and glucose-sensing technology. Depending upon the FDA clearance, Lilly anticipates these technologies to hit the market in two to three years.

A couple of decades back, novel product launches had not been the order of the day, despite a steady increase in the incidences of diabetes, leading a massive gap between the disease prevalence and disease management tools. Today however, with the pace of product diversification continuing to race ahead, industry analysts expect this trend to help bridge the critical gap in the current diabetes healthcare landscape. The insulin pen market in this regard is expected to witness a massive remuneration portfolio, having bagged over USD 6.5 billion in 2017. One of the fundamental reasons behind the enviable popularity of insulin pens is their increasing demand in the low-income group.

Insulin pump is another important product gaining considerable traction, given its minimally invasive nature. The insulin pumps are not only endowed with the unmatched combination of features like convenience, efficiency, needless insulin delivery, and portability, but they also eliminate the necessity of daily insulin injection dosage. Reports claim the insulin pump market to witness a CAGR of 7.5% over 2018-2024, having garnered USD 1.9 billion in 2017. Looking at the pace of technological developments with respect to insulin pumps, it is quite undeniable that the insulin pump segment will be one of the most progressive business spaces to unfold in the following years. However, the high-product cost associated with these pumps is set to act as a major roadblock in the business expansion.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1649

Geographically, U.S. is one of the most outperforming region that has secured a major chunk in the insulin delivery devices market. Accounting for 95% of the overall regional share in 2017, U.S. has been a major revenue pocket for the global insulin delivery devices industry. The rising prevalence of diabetic population with the robust advancements in the healthcare services have been listed as the prime factors leading to increased product demand. Other emerging economies such as China and India are also expected to gain massive growth trends, given the rapid governmental initiatives undertaken to develop healthcare infrastructure and awareness regarding diabetes management.

It has been estimated that in the not-so-distant future, diabetes will turn out to be the 7th leading cause of mortality. In fact, according to WHO, an estimated 1.6 million deaths were directly linked to diabetes in 2015 and diabetes prevalence has been raising more prominently in the middle & low-income countries. This not-so-pleasant scenario has indeed been the most significant factors that has fortified the growth of insulin delivery devices market. The rapid pace of technological developments and introduction of novel products are sure to bring massive investment trends in this business sphere in the coming years. A report by Global Market Insights, Inc., forecast the overall insulin delivery devices market size to register a CAGR of 6.5% over 2018-2024.

Company Profiles :-

• Sanofi
• Eli Lilly
• Medtronic
• Novo Nordisk
• Insulet Corporation
• Becton and Dickinson
• Roche
• Ypsomed
• Wockhardt
• B Broun

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin delivery devices market 2018 – 2024 : Top Players – Sanofi, Ely Lilly, Novo Nordisk, Medtronic, Becton and Dickenson, Roche, Insulet Corporation, Ypsomed here

News-ID: 1193121 • Views: 1367

More Releases from Global Market Insights, Inc.

Hypochlorite Bleaches Market to hit US$ 300 Mn 2025 | Top Key Players like Adity …
As per the research report by Global Market Insights, Inc., Global Hypochlorite Bleaches Market to cross USD 300 million by 2025 and grow at 3.4% CAGR from 2019 to 2025. It has been projected that the Global hypochlorite bleaches market is expected to reach a consumption of around 485-kilo tons by 2025. Water scarcity as well as rising water costs have led to more emphasis being laid on water recycling and
Feminine Hygiene Products Market: Growing awareness regarding intimate health in …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Feminine Hygiene Products Market. One of the most hushed topics across the world is female hygiene, the negligence of which results in several diseases. Studies claim that nearly 30% to 60 % women across the globe develop urinary tract infection once in their lifetime, mainly due to negligence in proper intimate hygiene. Dearth of knowledge regarding the negative consequences of
Examination Gowns Market 2020 business trends & growth opportunities to 2026
Global Market Insights, Inc., announces an ongoing comprehensive report on the Examination Gowns Market. The exposure to various kinds of hospital acquired infections has led to a spate of health problems for the healthcare professionals as well has the patients. In this regard, experts have been massively shifting to adoption of personal protective equipment or clothing, examination gowns, protecting them from all kinds of infections. These gowns are present in the
Nonwoven Packaging Market to witness increased demand from pharmaceutical sector …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Nonwoven Packaging Market. With the world struggling to fight against negative consequences of industrialization and increased carbon emissions, nonwovens or nonwoven fabrics have emerged as an intrinsic solution for all ecological imbalances across the globe. These fabrics are made from staple fiber and long fibers, merged together by chemical, heat, or mechanical treatment. These are generally used in textile manufacturing

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin Delivery Devices Market - Insights
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin
Biosimilar Insulin Market Access
Boston, MA ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer
Biosimilar Insulin Market Access
ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact
Global Insulin Delivery Machine Market: By Types - Insulin Pens, Insulin Pumps, …
Latest industry research report on: Global Insulin Delivery Machine Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1181480 This report studies Insulin Delivery Machine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in